Pressmeddelande

09 Nov, 2017

Cantargia: Combined directed issue and fully guaranteed rights issue of 232 MSEK for its expanded clinical program of immuno-oncology antibody CAN04

Read the press release here: http://cantargia.com/en/investors/shareoffering